Melanocortin Agonist
$49.99
Cyclic melanocortin peptide (bremelanotide) for MC3R/MC4R pathway research. Lyophilized powder, ≥99% purity verified via HPLC and mass spectrometry. Certificate of Analysis included with every order. For research and laboratory use only.
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide closely related to PT-141, differing by a C-terminal hydroxyl in place of the amide. It acts as a melanocortin receptor agonist with notable activity at MC3R and MC4R, making it a common reference compound in central melanocortin pathway research.
Each vial contains pharmaceutical-grade lyophilized PT-141 powder, sealed under sterile conditions for maximum stability and shelf life. The compound is independently verified to ≥99% purity by third-party HPLC and mass spectrometry analysis.
Available as a 10mg lyophilized preparation to support in-vitro and preclinical research protocols.
| Compound | PT-141 (bremelanotide, cyclic α-MSH analog) |
| Purity | ≥99% (HPLC verified) |
| Form | Lyophilized powder |
| Size | 10mg |
| Storage | Store at -20°C. Protect from light. |
| Reconstitution | Bacteriostatic water or sterile saline |
| Molecular Target | Melanocortin receptors (MC3R, MC4R) |
| Sequence Length | 7 amino acids (cyclic lactam) |
| Testing | HPLC, Mass Spectrometry, Endotoxin |
| COA | Included with every order |
PT-141 has been studied in preclinical and in-vitro research contexts. Key areas of published research include:
All research references are available upon request. This compound is sold exclusively for in-vitro and laboratory research use.
All sales are final once shipped. Refunds available only if order hasn't shipped or wrong product received — contact us within 7 days.
PT-141
$49.99
All products are for research and laboratory use only. Not for human consumption.
